Morphine Versus Ketamine as Adjuvants in Paravertebral Blocks (Annie-Dimitr)
Primary Purpose
Pain, Postoperative, Pain, Acute, Pain, Chronic
Status
Active
Phase
Not Applicable
Locations
Greece
Study Type
Interventional
Intervention
local anesthetic-morphine
local anesthetic-ketamine
local anesthetic
Sponsored by
About this trial
This is an interventional prevention trial for Pain, Postoperative
Eligibility Criteria
Inclusion Criteria:
- patients undergoing elective thoracotomy for any cause
- American Society of Anesthesiologists class I-III (ASA I-III)
Exclusion Criteria:
- known allergy to local anesthetic
- local inflammation
- paravertebral tumor
- severe respiratory distress ( breathing dependence on accessory muscles)
- severe spinal deformities
- severe ipsilateral diaphragmatic paresis
- morbid obesity (BMI>35 kg/m2)
- blood coagulation disorders
- known contraindication for administration of ketamine or morphine
- psychiatric disorders
- severe cardiovascular disease
- systematic use of opioids due to chronic pain
- renal or hepatic failure
- patients who refuse to participate
Sites / Locations
- Aretaieion University Hospital
- KAT General Hospital of Athens
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Active Comparator
Active Comparator
Active Comparator
Arm Label
local anesthetic and morphine group
local anesthetic and ketamine group
local anesthetic group
Arm Description
paravertebral block with local anesthetic and morphine, followed by a continuous infusion of local anesthetic and morphine in the paravertebral space
paravertebral block with local anesthetic and ketamine, followed by a continuous infusion of local anesthetic and ketamine in the paravertebral space
paravertebral block with local anesthetic only, followed by a continuous infusion of local anesthetic only in the paravertebral space
Outcomes
Primary Outcome Measures
morphine consumption in the first 48 hours
patients will be followed for cumulative morphine consumption through patient-controlled analgesia device for 48 hours postoperatively
Secondary Outcome Measures
morphine consumption in Post-Anesthesia Care Unit (PACU)
mg of morphine requested during patient PACU stay
pain score on arrival to Post-Anesthesia Care Unit (PACU)
pain score by the use of Numeric Rating Scale (NRS) on arrival to PACU, ranging from 0 to 10, where 0 means "no pain" and 10 means "worst pain imaginable"
pain score 6 hours postoperatively
pain score by the use of Numeric Rating Scale (NRS) 6 hours postoperatively, ranging from 0 to 10, where 0 means "no pain" and 10 means "worst pain imaginable"
pain score 12 hours postoperatively
pain score by the use of Numeric Rating Scale (NRS) 12 hours postoperatively, ranging from 0 to 10, where 0 means "no pain" and 10 means "worst pain imaginable"
pain score 24 hours postoperatively
pain score by the use of Numeric Rating Scale (NRS) 24 hours postoperatively, ranging from 0 to 10, where 0 means "no pain" and 10 means "worst pain imaginable"
pain score 48 hours postoperatively
pain score by the use of Numeric Rating Scale (NRS) 48 hours postoperatively, ranging from 0 to 10, where 0 means "no pain" and 10 means "worst pain imaginable"
morphine consumption in the first 6 hours
patients will be followed for cumulative morphine consumption through patient-controlled analgesia device for 6 hours postoperatively
morphine consumption in the first 12 hours
patients will be followed for cumulative morphine consumption through patient-controlled analgesia device for 12 hours postoperatively
morphine consumption in the first 24 hours
patients will be followed for cumulative morphine consumption through patient-controlled analgesia device for 24 hours postoperatively
side effects postoperatively
patients will be monitored for side-effects of the administered agents postoperatively
satisfaction from postoperative analgesia
satisfaction from postoperative analgesia on a four-point Likert scale with 1 marked as minimal satisfaction and 4 as maximal satisfaction
morphine requirement during surgery
dose of required morphine administered intraoperatively
time to first request for analgesia
the time for the first patient request for analgesia will be noted
hospitalization time
duration of hospital stay after surgery in days
incidence of chronic pain 3 months after surgery
occurrence of chronic pain at the site of the operation 3 months after surgery, with the use of the Numeric Rating Scale (NRS), at rest and during movement
incidence of chronic pain 6 months after surgery
occurrence of chronic pain at the site of the operation 6 months after surgery, with the use of the Numeric Rating Scale (NRS), at rest and during movement
Full Information
NCT ID
NCT04852484
First Posted
April 16, 2021
Last Updated
May 3, 2023
Sponsor
Aretaieion University Hospital
Collaborators
KAT General Hospital
1. Study Identification
Unique Protocol Identification Number
NCT04852484
Brief Title
Morphine Versus Ketamine as Adjuvants in Paravertebral Blocks
Acronym
Annie-Dimitr
Official Title
Morphine Versus Ketamine as Adjuvants in Ultrasound-guided Paravertebral Thoracic Blocks in Elective Thoracic Surgery
Study Type
Interventional
2. Study Status
Record Verification Date
May 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
April 16, 2021 (Actual)
Primary Completion Date
April 16, 2024 (Anticipated)
Study Completion Date
April 16, 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Aretaieion University Hospital
Collaborators
KAT General Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The aim of this study will be to compare the effects of morphine versus ketamine when they are used as adjuvants to the local anesthetic in paravertebral nerve blocks performed with the aid of ultrasound. Furthermore, a group of local anesthetic without an adjuvant, will also be compared to the two groups
Detailed Description
Elective thoracotomies are usually performed for removal of pathological masses in the mediastinum, lung parenchyma and upper gastrointestinal system. They are considered to be painful operations, related to both acute and chronic pain (post- thoracotomy pain syndrome), the latter lasting for a minimum period of 2 months.
Post-operative thoracic pain is associated often with diaphragmatic dysfunction, which can also lead to atelectasis and pneumonia and post-operative pulmonary complications in general.
Several techniques have been tried in order to minimize such events. Thoracic epidural analgesia, intravenous analgesia, intercostal blocks, local infiltration of local anesthetics by the surgeon are some of them.
Paravertebral thoracic blocks have become increasingly popular in recent years since they are less likely to cause neurologic complications than thoracic epidural analgesia. Moreover, bleeding disorders, and use of anti-coagulant and anti- thrombotic medications, which are considered as contraindications to an epidural procedure, are not strict contraindications in the performance of paravertebral blocks, especially when they are performed under ultrasonographic guidance.
Ropivacaine and Levobupivacaine are the most popular local anesthetics that have been used. Moreover, several adjuvants have been added to them in order to enhance the effects of those blocks. Dexamethasone, Morphine, Dexmedetomidine, Clonidine, Ketamine, Magnesium Sulphate are some of them. Results are variable.
The rationale behind adjuvants used to enhance effects of local anesthetics is the fact that some seem to act directly in the spinal cord receptors and the central nervous system. The effect of morphine on the dorsal horns of the spinal cord has been extensively studied in the past. Due to its limited lipophilicity, it is assumed that administering the specific drug to the paravertebral space could lead to its transfer and action on the dorsal horns.
On the other hand, the action of ketamine seems to be by blocking N-Methyl-D-Aspartate (NMDA) receptors in the spinal cord. It is also considered to have an effect on voltage sensitive Ca2+ channels, opioid receptors, and monoaminergic receptors. Therefore, it is considered overall to affect nociception.
Overall, it is assumed that morphine might have an effect on the dorsal horns of the spinal cord, and ketamine on NMDA receptors at "higher pain centers". It is also assumed that there will be some degree of systemic absorption due to the rich vascular supply of the specific area. The investigators aim to compare the effects of those two when they are used as adjuvants to the local anesthetic in paravertebral nerve blocks performed with the aid of ultrasound. Furthermore, a group of local anesthetic without an adjuvant, will also be compared.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pain, Postoperative, Pain, Acute, Pain, Chronic, Pain, Neuropathic, Morphine, Ketamine, Analgesia
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
90 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
local anesthetic and morphine group
Arm Type
Active Comparator
Arm Description
paravertebral block with local anesthetic and morphine, followed by a continuous infusion of local anesthetic and morphine in the paravertebral space
Arm Title
local anesthetic and ketamine group
Arm Type
Active Comparator
Arm Description
paravertebral block with local anesthetic and ketamine, followed by a continuous infusion of local anesthetic and ketamine in the paravertebral space
Arm Title
local anesthetic group
Arm Type
Active Comparator
Arm Description
paravertebral block with local anesthetic only, followed by a continuous infusion of local anesthetic only in the paravertebral space
Intervention Type
Drug
Intervention Name(s)
local anesthetic-morphine
Other Intervention Name(s)
local anesthetic and morphine administered paravertebrally
Intervention Description
Before the operation, 19 mL of 0.5% Ropivacaine + 2 mg of morphine (20 mL in total) will be injected in the paravertebral space. Afterwards, there will be a pump of 500 ml of 0.2 % ropivacaine + 6 mg of morphine connected to the catheter after the end of the surgery, administered continuously at a rate of 10 mL/hr
Intervention Type
Drug
Intervention Name(s)
local anesthetic-ketamine
Other Intervention Name(s)
local anesthetic and ketamine administered paravertebrally
Intervention Description
Before the operation, 19 mL of 0.5% Ropivacaine + 50 mg of ketamine (20 mL in total) will be injected in the paravertebral space. Afterwards, there will be a pump of 500 ml of 0.2 % ropivacaine + 200 mg of ketamine connected to the catheter after the end of the surgery, administered continuously at a rate of 10 mL/hr
Intervention Type
Drug
Intervention Name(s)
local anesthetic
Other Intervention Name(s)
local anesthetic administered paravertebrally
Intervention Description
Before the operation, 19 mL of 0.5% Ropivacaine + 1 mL of normal saline (20 mL in total) will be injected in the paravertebral space. Afterwards, there will be a pump of 500 ml of 0.2 % ropivacaine connected to the catheter after the end of the surgery, administered continuously at a rate of 10 mL/hr
Primary Outcome Measure Information:
Title
morphine consumption in the first 48 hours
Description
patients will be followed for cumulative morphine consumption through patient-controlled analgesia device for 48 hours postoperatively
Time Frame
48 hours postoperatively
Secondary Outcome Measure Information:
Title
morphine consumption in Post-Anesthesia Care Unit (PACU)
Description
mg of morphine requested during patient PACU stay
Time Frame
24 hours postoperatively
Title
pain score on arrival to Post-Anesthesia Care Unit (PACU)
Description
pain score by the use of Numeric Rating Scale (NRS) on arrival to PACU, ranging from 0 to 10, where 0 means "no pain" and 10 means "worst pain imaginable"
Time Frame
immediately postoperatively
Title
pain score 6 hours postoperatively
Description
pain score by the use of Numeric Rating Scale (NRS) 6 hours postoperatively, ranging from 0 to 10, where 0 means "no pain" and 10 means "worst pain imaginable"
Time Frame
6 hours postoperatively
Title
pain score 12 hours postoperatively
Description
pain score by the use of Numeric Rating Scale (NRS) 12 hours postoperatively, ranging from 0 to 10, where 0 means "no pain" and 10 means "worst pain imaginable"
Time Frame
12 hours postoperatively
Title
pain score 24 hours postoperatively
Description
pain score by the use of Numeric Rating Scale (NRS) 24 hours postoperatively, ranging from 0 to 10, where 0 means "no pain" and 10 means "worst pain imaginable"
Time Frame
24 hours postoperatively
Title
pain score 48 hours postoperatively
Description
pain score by the use of Numeric Rating Scale (NRS) 48 hours postoperatively, ranging from 0 to 10, where 0 means "no pain" and 10 means "worst pain imaginable"
Time Frame
48 hours postoperatively
Title
morphine consumption in the first 6 hours
Description
patients will be followed for cumulative morphine consumption through patient-controlled analgesia device for 6 hours postoperatively
Time Frame
6 hours postoperatively
Title
morphine consumption in the first 12 hours
Description
patients will be followed for cumulative morphine consumption through patient-controlled analgesia device for 12 hours postoperatively
Time Frame
12 hours postoperatively
Title
morphine consumption in the first 24 hours
Description
patients will be followed for cumulative morphine consumption through patient-controlled analgesia device for 24 hours postoperatively
Time Frame
24 hours postoperatively
Title
side effects postoperatively
Description
patients will be monitored for side-effects of the administered agents postoperatively
Time Frame
96 hours postoperatively
Title
satisfaction from postoperative analgesia
Description
satisfaction from postoperative analgesia on a four-point Likert scale with 1 marked as minimal satisfaction and 4 as maximal satisfaction
Time Frame
48 hours postoperatively
Title
morphine requirement during surgery
Description
dose of required morphine administered intraoperatively
Time Frame
intraoperatively
Title
time to first request for analgesia
Description
the time for the first patient request for analgesia will be noted
Time Frame
during stay in Post-Anesthesia Care Unit, 24 hours postoperatively
Title
hospitalization time
Description
duration of hospital stay after surgery in days
Time Frame
7 days postoperatively
Title
incidence of chronic pain 3 months after surgery
Description
occurrence of chronic pain at the site of the operation 3 months after surgery, with the use of the Numeric Rating Scale (NRS), at rest and during movement
Time Frame
3 months after surgery
Title
incidence of chronic pain 6 months after surgery
Description
occurrence of chronic pain at the site of the operation 6 months after surgery, with the use of the Numeric Rating Scale (NRS), at rest and during movement
Time Frame
6 months after surgery
10. Eligibility
Sex
All
Minimum Age & Unit of Time
25 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
patients undergoing elective thoracotomy for any cause
American Society of Anesthesiologists class I-III (ASA I-III)
Exclusion Criteria:
known allergy to local anesthetic
local inflammation
paravertebral tumor
severe respiratory distress ( breathing dependence on accessory muscles)
severe spinal deformities
severe ipsilateral diaphragmatic paresis
morbid obesity (BMI>35 kg/m2)
blood coagulation disorders
known contraindication for administration of ketamine or morphine
psychiatric disorders
severe cardiovascular disease
systematic use of opioids due to chronic pain
renal or hepatic failure
patients who refuse to participate
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kassiani Theodoraki, PhD, DESA
Organizational Affiliation
Aretaieion University Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Aretaieion University Hospital
City
Athens
ZIP/Postal Code
115 28
Country
Greece
Facility Name
KAT General Hospital of Athens
City
Athens
Country
Greece
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
18456219
Citation
Gerner P. Postthoracotomy pain management problems. Anesthesiol Clin. 2008 Jun;26(2):355-67, vii. doi: 10.1016/j.anclin.2008.01.007.
Results Reference
background
PubMed Identifier
29169795
Citation
D'Ercole F, Arora H, Kumar PA. Paravertebral Block for Thoracic Surgery. J Cardiothorac Vasc Anesth. 2018 Apr;32(2):915-927. doi: 10.1053/j.jvca.2017.10.003. Epub 2017 Oct 4.
Results Reference
background
PubMed Identifier
29720754
Citation
El Mourad MB, Amer AF. Effects of adding dexamethasone or ketamine to bupivacaine for ultrasound-guided thoracic paravertebral block in patients undergoing modified radical mastectomy: A prospective randomized controlled study. Indian J Anaesth. 2018 Apr;62(4):285-291. doi: 10.4103/ija.IJA_791_17.
Results Reference
background
PubMed Identifier
32582491
Citation
Ahmed MJ, Ur Rehman A, Arshad RM, Amjad MWA, Khan Z, Furqan A. Efficacy of Dexmedetomidine vs Morphine as an Adjunct in a Paravertebral Block with Bupivacaine in Postoperative Analgesia Following Modified Radical Mastectomy. Cureus. 2020 May 22;12(5):e8231. doi: 10.7759/cureus.8231.
Results Reference
background
PubMed Identifier
30254483
Citation
Mao Y, Zuo Y, Mei B, Chen L, Liu X, Zhang Z, Gu E. Efficacy of perineural dexamethasone with ropivacaine in thoracic paravertebral block for postoperative analgesia in elective thoracotomy: a randomized, double-blind, placebo-controlled trial. J Pain Res. 2018 Sep 11;11:1811-1819. doi: 10.2147/JPR.S164225. eCollection 2018.
Results Reference
background
PubMed Identifier
7367037
Citation
Maruyama Y, Shimoji K, Shimizu H, Sato Y, Kuribayashi H, Kaieda R. Effects of morphine of human spinal cord and peripheral nervous activities. Pain. 1980 Feb;8(1):63-73. doi: 10.1016/0304-3959(80)90090-1.
Results Reference
background
PubMed Identifier
10947756
Citation
Kathirvel S, Sadhasivam S, Saxena A, Kannan TR, Ganjoo P. Effects of intrathecal ketamine added to bupivacaine for spinal anaesthesia. Anaesthesia. 2000 Sep;55(9):899-904. doi: 10.1046/j.1365-2044.2000.01472.x.
Results Reference
background
Learn more about this trial
Morphine Versus Ketamine as Adjuvants in Paravertebral Blocks
We'll reach out to this number within 24 hrs